Publication | Open Access
Ponatinib treatment promotes arterial thrombosis and hyperactive platelets
30
Citations
16
References
2019
Year
ThrombopoiesisThrombosisThrombosis RiskCardiovascular DiseaseBlood PlateletHematologyPharmacologyCardiovascular PharmacologyPlatelet ReactivityPharmacotherapyArterial ThrombosisPlatelet AntagonistMedicineAnticoagulant
Key Points Ponatinib therapy heightens arterial thrombosis and platelet reactivity. Concurrent pioglitazone treatment reverses heightened thrombosis risk and platelet reactivity induced by ponatinib.
| Year | Citations | |
|---|---|---|
Page 1
Page 1